L.B. Foster Company (FSTR)
USD 26.68
(-6.55%)
USD 26.68
(-6.55%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 37.37 Million | -10.57 Million | -1.06 Million | 16.91 Million | 29.29 Million | 25.96 Million |
| Net Income | 1.29 Million | -45.67 Million | 3.47 Million | 25.82 Million | 42.56 Million | -31.16 Million |
| Depreciation & Amortization | 15.26 Million | 14.77 Million | 13.88 Million | 13.57 Million | 17.63 Million | 18.59 Million |
| Deferred income taxes | -1.85 Million | 35.78 Million | 139 Thousand | -4.31 Million | -29.51 Million | -1.59 Million |
| Stock-based compensation | 4.17 Million | 2.38 Million | 1.94 Million | 1.13 Million | 3.15 Million | 3.83 Million |
| Change in working capital | 15.92 Million | -25.82 Million | -17.55 Million | -15.97 Million | -7.93 Million | -8.4 Million |
| Other non-cash items | 2.56 Million | 7.97 Million | -2.95 Million | -3.33 Million | 3.38 Million | 44.7 Million |
| Investing Cash Flow | 2.06 Million | -56.41 Million | 17.82 Million | -8.04 Million | -7.68 Million | 2.24 Million |
| Investments in PPE | -4.93 Million | -7.63 Million | -4.62 Million | -9.17 Million | -8.83 Million | -5.25 Million |
| Acquisitions | -1.24 Million | -57.85 Million | -295 Thousand | -1.15 Million | 930 Thousand | 3.87 Million |
| Investment purchases | - | - | -66 Thousand | - | - | -1.48 Million |
| Sales/Maturities of investments | - | - | 66 Thousand | - | - | 3.87 Million |
| Other Investing Activities | 8.24 Million | 9.06 Million | 22.73 Million | 2.29 Million | 221 Thousand | 1.23 Million |
| Financing Cash Flow | -39.29 Million | 60.24 Million | -13.9 Million | -15.29 Million | -18.24 Million | -55.3 Million |
| Debt repayment | -208.66 Million | -188.43 Million | -183.37 Million | -172.89 Million | -210.32 Million | -55.02 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -2.62 Million | -410 Thousand | -732 Thousand | -1.66 Million | -621 Thousand | -316 Thousand |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 171.99 Million | 249.08 Million | 170.2 Million | 159.26 Million | 192.69 Million | 37 Thousand |
| Accounts receivables | 27.36 Million | -25.06 Million | 2.29 Million | 15.72 Million | 7.92 Million | -11.43 Million |
| Accounts payables | -3.75 Million | 10.06 Million | -13.64 Million | -8.94 Million | -12.69 Million | 24.21 Million |
| Inventory | -6.98 Million | -11.79 Million | -3.97 Million | 3.27 Million | 6.68 Million | -23.4 Million |
| Other working capital | -702 Thousand | 971 Thousand | -2.23 Million | -26.02 Million | -9.85 Million | 2.22 Million |
| Cash at beginning of period | 2.88 Million | 10.37 Million | 7.56 Million | 14.17 Million | 10.28 Million | 37.67 Million |
| Cash at end of period | 2.56 Million | 2.88 Million | 10.37 Million | 7.56 Million | 14.17 Million | 10.28 Million |
| Capital Expenditure | -4.93 Million | -7.63 Million | -4.62 Million | -9.17 Million | -8.83 Million | -5.25 Million |
| Effect of forex changes on cash | -468 Thousand | -736 Thousand | -47 Thousand | -195 Thousand | 525 Thousand | -308 Thousand |
| Net cash flow / Change in cash | -322 Thousand | -7.49 Million | 2.8 Million | -6.61 Million | 3.89 Million | -27.39 Million |
| Free Cash Flow | 32.44 Million | -18.2 Million | -5.68 Million | 7.73 Million | 20.46 Million | 20.71 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.84 Million | 4.43 Million | 1.29 Million | -470 Thousand | 447 Thousand | 3.49 Million |
| Depreciation & Amortization | 3.48 Million | 3.59 Million | 15.26 Million | 3.69 Million | 3.83 Million | 3.85 Million |
| Deferred income taxes | -20 Thousand | -41 Thousand | -1.85 Million | 106 Thousand | -248 Thousand | -477 Thousand |
| Stock-based compensation | 1.31 Million | 1.03 Million | 4.17 Million | 1.42 Million | 928 Thousand | 945 Thousand |
| Change in working capital | -11.71 Million | -27.27 Million | 15.92 Million | 17.46 Million | 13.65 Million | -18.77 Million |
| Other non-cash items | 13.97 Million | 13.49 Million | 2.56 Million | -150 Thousand | 22 Thousand | 690 Thousand |
| Investing Cash Flow | -1.67 Million | 1.2 Million | 2.06 Million | -3.73 Million | -1.91 Million | 3.05 Million |
| Investments in PPE | -2.05 Million | -2.29 Million | -4.93 Million | -2.14 Million | -1.28 Million | -796 Thousand |
| Acquisitions | 380 Thousand | 3.5 Million | -1.24 Million | -9.28 Million | -629 Thousand | 3.32 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 379.99 Thousand | 1.2 Million | 8.24 Million | 7.7 Million | - | 523 Thousand |
| Financing Cash Flow | 7.51 Million | 21.29 Million | -39.29 Million | -18.17 Million | -17.55 Million | 8.45 Million |
| Debt repayment | -9.04 Million | -22.91 Million | -208.66 Million | -58.55 Million | -54.86 Million | -40.11 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1.52 Million | -1.61 Million | -2.62 Million | -1.43 Million | -216 Thousand | -668 Thousand |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 28.81 Million | 21.29 Million | 171.99 Million | 41.81 Million | 37.52 Million | 49.24 Million |
| Accounts receivables | -15.12 Million | 1.09 Million | 27.36 Million | 11.44 Million | 9.34 Million | -19.65 Million |
| Accounts payables | 2.84 Million | 2.39 Million | -3.75 Million | -4.95 Million | 736 Thousand | -4.45 Million |
| Inventory | 5.72 Million | -12.37 Million | -6.98 Million | 9.05 Million | -2.97 Million | 2.49 Million |
| Other working capital | -5.16 Million | -18.39 Million | -702 Thousand | 1.91 Million | 6.55 Million | 2.84 Million |
| Cash at beginning of period | 3.14 Million | 2.56 Million | 2.88 Million | 2.96 Million | 3.88 Million | 2.63 Million |
| Cash at end of period | 4.02 Million | 3.14 Million | 2.56 Million | 2.56 Million | 2.96 Million | 3.88 Million |
| Capital Expenditure | -2.05 Million | -2.29 Million | -4.93 Million | -2.14 Million | -1.28 Million | -796 Thousand |
| Effect of forex changes on cash | -16 Thousand | -55 Thousand | -468 Thousand | -568 Thousand | -78 Thousand | -8000.00 |
| Net cash flow / Change in cash | 873 Thousand | 588 Thousand | -322 Thousand | -409 Thousand | -911 Thousand | 1.24 Million |
| Free Cash Flow | -7 Million | -24.15 Million | 32.44 Million | 19.91 Million | 17.35 Million | -11.06 Million |
TOP-R
BALPHARMA
DII-B
000810
9225
HDYNQ